4//SEC Filing
Royer Scott E. 4
Accession 0000891839-20-000050
CIK 0001205922other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:23 PM ET
Size
9.3 KB
Accession
0000891839-20-000050
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Royer Scott E.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-25+2,000→ 2,000 totalExercise: $6.07Exp: 2030-02-24→ Common Stock (2,000 underlying)
Holdings
- 3,999
Common Stock
- 25,000
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2028-02-21→ Common Stock (25,000 underlying) - 2,000
Stock Option (Right to Buy)
Exercise: $3.90Exp: 2029-03-14→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]This option initially vested in quarterly installments of 1,562.5 shares for each of four quarters beginning on May 21, 2018. The remainder vests in three equal annual installments beginning February 21, 2020.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747756
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:23 PM ET
- Size
- 9.3 KB